{"AMCR": {"Ticker": "AMCR", "Company": "Amcor", "Sector": "Materials", "Updated": "2022-03-25", "Rating": [{"Date": "2022-03-25", "Rating": "Initiated", "Organization": "Truist", "Rating_Change": "Hold", "Target_Change": "$12"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 1, "Period": "180 days", "Analists": ["Truist"], "Price_Target": 12.0}, "ANSS": {"Ticker": "ANSS", "Company": "Ansys", "Sector": "Information Technology", "Updated": "2022-03-25", "Rating": [{"Date": "2022-03-25", "Rating": "Initiated", "Organization": "Daiwa Securities", "Rating_Change": "Sell", "Target_Change": "$253"}, {"Date": "2022-01-06", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": "$419 to $405"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Analists": ["Daiwa Securities", "Robert W. Baird"], "Price_Target": 329.0}, "AVY": {"Ticker": "AVY", "Company": "Avery Dennison", "Sector": "Materials", "Updated": "2022-03-25", "Rating": [{"Date": "2022-03-25", "Rating": "Initiated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$227"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Analists": ["Truist"], "Price_Target": 227.0}, "CCL": {"Ticker": "CCL", "Company": "Carnival Corporation", "Sector": "Consumer Discretionary", "Updated": "2022-03-25", "Rating": [{"Date": "2022-03-25", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-01-05", "Rating": "Resumed", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$24"}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Analists": ["Jefferies", "Argus"], "Price_Target": 11.0}, "FTNT": {"Ticker": "FTNT", "Company": "Fortinet", "Sector": "Information Technology", "Updated": "2022-03-25", "Rating": [{"Date": "2022-03-25", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$385 to $355"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$325 to $360"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "Wedbush", "Rating_Change": "Outperform", "Target_Change": "$400 to $350"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$370 to $340"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "Raymond James", "Rating_Change": "Outperform", "Target_Change": "$380 to $350"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "Mizuho", "Rating_Change": "Neutral", "Target_Change": "$325 to $340"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": "$320 to $305"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$390 to $405"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform", "Target_Change": "$353 to $365"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$355 to $364"}, {"Date": "2022-01-25", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$390"}], "Score": 0.82, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 11, "Period": "180 days", "Analists": ["UBS", "Deutsche Bank", "Citigroup", "Barclays", "Mizuho", "BMO Capital Markets", "BofA Securities", "Wells Fargo", "Raymond James", "Wedbush"], "Price_Target": 356.73}, "ISRG": {"Ticker": "ISRG", "Company": "Intuitive Surgical", "Sector": "Health Care", "Updated": "2022-03-25", "Rating": [{"Date": "2022-03-25", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$340"}, {"Date": "2022-03-02", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$340"}, {"Date": "2022-02-02", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$317 to $325"}, {"Date": "2022-01-31", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Overweight", "Target_Change": "$300 to $310"}, {"Date": "2022-01-25", "Rating": "Downgrade", "Organization": "Redburn", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2022-01-21", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": "$370 to $360"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$381 to $350"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$338 to $317"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$370 to $325"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Robert W. Baird", "Rating_Change": "Outperform", "Target_Change": "$370 to $315"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Raymond James", "Rating_Change": "Outperform", "Target_Change": "$383 to $334"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Piper Sandler", "Rating_Change": "Neutral", "Target_Change": "$330 to $300"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$375 to $325"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Evercore ISI", "Rating_Change": "In-line", "Target_Change": "$340 to $290"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": "$323 to $300"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "BTIG Research", "Rating_Change": "Buy", "Target_Change": "$372 to $360"}, {"Date": "2022-01-10", "Rating": "Upgrade", "Organization": "BTIG Research", "Rating_Change": "Neutral to Buy", "Target_Change": "$372"}], "Score": 1.24, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 17, "Period": "180 days", "Analists": ["Morgan Stanley", "Redburn", "UBS", "Deutsche Bank", "Citigroup", "RBC Capital Mkts", "BTIG Research", "Stifel", "BofA Securities", "Evercore ISI", "Wells Fargo", "Raymond James", "Robert W. Baird", "Piper Sandler"], "Price_Target": 308.59}, "PRU": {"Ticker": "PRU", "Company": "Prudential Financial", "Sector": "Financials", "Updated": "2022-03-25", "Rating": [{"Date": "2022-03-25", "Rating": "Downgrade", "Organization": "Credit Suisse", "Rating_Change": "Outperform to Neutral", "Target_Change": "$131 to $121"}, {"Date": "2022-01-26", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Underperform", "Target_Change": "$93"}, {"Date": "2022-01-21", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": "$131"}, {"Date": "2022-01-05", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "In-line to Underperform", "Target_Change": "$99 to $109"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Analists": ["Credit Suisse", "Wolfe Research", "Evercore ISI", "Jefferies"], "Price_Target": 113.5}}